Abstract:The authors warmly thank the members of the family, nurses of endocrinology unit for recruiting the patients, and laboratory technicians for their assistance. Research ethics: Data were anonymized but the age and the sex were known. The study was carried out according to The Code of Ethics of the World Medical Association (Declaration of Helsinki) and obtained the agreement of the Ethical Committee of the Ethics Committee of the Hospices Civils de Lyon (CNIL N0°920434; GENELIP/ASAP study; clinical trial registration number: NCT03939039, https://clinicaltrials.gov/ct2/show/NCT03939039). Informed consent: This study was carried put according to the French ethic laws. Author contributions: Clinical assessments: PM, GR. Experiments: conception and design: CP, DC, PB, MDF. Performed the experiments: MBR, CP, DC, OM, PB, MDF. Analyzed the data: MBR, CP, DC, OM, PB, MDF. Wrote and reviewed the paper: MBR, PM, CP, DC, PB, MDF. Approved the version to be published, agreed to be accountable for all aspects of the work: all authors. Competing interests: The authors state no conflict of interest. Research funding: None declared. Data availability: Available on request, respecting ethical laws. 1. Marmontel, O, Rollat-Farnier, PA, Wozny, A, Charrière, S, Vanhoye, X, Simonet, T, et al.. Development of a new expanded next-generation sequencing panel for genetic diseases involved in dyslipidemia. Clin Genet 2020;98:589–94. https://doi.org/10.1111/cge.13832. Search in Google Scholar PubMed 2. Rimbert, A, Vanhoye, X, Coulibaly, D, Marrec, M, Pichelin, M, Charrière, S, et al.. Phenotypic differences between polygenic and monogenic hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol 2020;41:e63–71. https://doi.org/10.1161/atvbaha.120.315491. Search in Google Scholar PubMed 3. Bredefeld, C, Hussain, MM, Averna, M, Black, DD, Brin, MF, Burnett, JR, et al.. Guidance for the diagnosis and treatment of hypolipidemia disorders. J Clin Lipidol 2022;16:797–812. https://doi.org/10.1016/j.jacl.2022.08.009. Search in Google Scholar PubMed 4. Witsch-Baumgartner, M, Schwentner, I, Gruber, M, Benlian, P, Bertranpetit, J, Bieth, E, et al.. Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations. J Med Genet 2008;45:200–9. https://doi.org/10.1136/jmg.2007.053520. Search in Google Scholar PubMed 5. Peng, Y, Myers, R, Zhang, W, Alexov, E. Computational investigation of the missense mutations in DHCR7 gene associated with Smith-Lemli-Opitz syndrome. Int J Mol Sci 2018;19:141. https://doi.org/10.3390/ijms19010141. Search in Google Scholar PubMed PubMed Central 6. Patrono, C, Dionisi-Vici, C, Giannotti, A, Bembi, B, Digilio, MC, Rizzo, C, et al.. Two novel mutations of the human Δ7-sterol reductase (DHCR7) gene in children with Smith-Lemli-Opitz syndrome. Mol Cell Probes 2002;16:315–8. https://doi.org/10.1006/mcpr.2002.0426. Search in Google Scholar PubMed 7. Boland, MR, Tatonetti, NP. Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review. Pharmacogenomics J 2016;16:411–29. https://doi.org/10.1038/tpj.2016.48. Search in Google Scholar PubMed PubMed Central 8. Porter, FD. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet 2008;16:535–41. https://doi.org/10.1038/ejhg.2008.10. Search in Google Scholar PubMed 9. Kelley, RI, Hennekam, RC. The Smith-Lemli-Opitz syndrome. J Med Genet 2000;37:321–35. https://doi.org/10.1136/jmg.37.5.321. Search in Google Scholar PubMed PubMed Central <span class="reference-label d-inlineblock me-4 -Abstract Truncated-

Smith-Lemli-Opitz (RHS) syndrome: holoprosencephaly and homozygous IVS8-1G-->C genotype

Smith-Lemli-Opitz syndrome: the first malformation syndrome associated with defective cholesterol synthesis

Prenatal presentation and diagnostic evaluation of suspected Smith-Lemli-Opitz (RSH) syndrome

Difficult prenatal diagnosis in mild Smith-Lemli-Opitz syndrome

Atypical case of Smith-Lemli-Opitz syndrome: implications for diagnosis

Cyclopia (synophthalmia) in Smith-Lemli-Opitz syndrome: First reported case and consideration of mechanism

Prenatal diagnosis of holoprosencephaly associated with Smith-Lemli-Opitz syndrome (SLOS) in a 46,XX fetus

Prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS) by DHCR7 mutation analysis

Antenatal therapy of Smith-Lemli-Opitz syndrome

Incidence of Smith-Lemli-Opitz syndrome in Ontario, Canada

Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome

Assessing Postnatal Mortality in Smith–Lemli–Opitz Syndrome

Elevated cerebrospinal fluid glial fibrillary acidic protein levels in Smith-Lemli-Opitz syndrome

Smith-Lemli-Opitz Syndrome with Biallelic c.1295A>G (p.Tyr432Cys) Variant in the DHCR7 Gene in a 73-Year-Old Woman: Report of the Oldest Patient

Diagnostic challenge between a frequent polygenic hypocholesterolemia and an unusual Smith Lemli Opitz syndrome related to bi-allelic DHCR7 mutations

Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome

Maternal urinary steroid profiles in prenatal diagnosis of Smith-Lemli-Opitz syndrome: first patient series comparing biochemical and molecular studies

Differences between predicted and established diagnoses of Smith-Lemli-Opitz syndrome in the Polish population: underdiagnosis or loss of affected fetuses?

Midgestational maternal urine steroid markers of fetal Smith-Lemli-Opitz (SLO) syndrome (7-dehydrocholesterol 7-reductase deficiency)

Potential of sterol analysis by liquid chromatography-tandem mass spectrometry for the prenatal diagnosis of Smith-Lemli-Opitz syndrome

Equine type estrogens produced by a pregnant woman carrying a Smith-Lemli-Opitz syndrome fetus